Get the (PSTI) Report Here
Trade with Jim Cramer 14 Days FREE
Pluristem's successful stem cell trial last week on muscle injuries is an important first step for the company, says the company's CEO Zami Aberman.
Follow Real Money's Wall Street Pros to receive real-time investing alerts
Already a Subscriber? Login